INSR, insulin receptor, 3643

N. diseases: 452; N. variants: 109
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 Biomarker group BEFREE Therefore, our results identify SCF<sup>FBXO2</sup> as an E3 ligase for the IR in the liver, which might provide a novel therapeutic target for treating T2DM and related metabolic disorders. 27932386 2017
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 GeneticVariation group BEFREE Thus, it was found that the INSR rs2059806 SNP is also associated with pre-eclampsia phenotypes in two independent cohorts suggesting that genetic susceptibility may be implicated in the link between pre-eclampsia and subsequent vascular and metabolic diseases. 28117222 2017
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 GeneticVariation group BEFREE The INSR rs2059806 SNP previously associated with adult vascular and metabolic diseases is also associated with SGA pregnancies. 26089371 2015
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 Biomarker group BEFREE Defective hepatic insulin receptor (IR) signalling is a pathogenic manifestation of metabolic disorders including obesity and diabetes. 26387534 2015
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 AlteredExpression group BEFREE Since IR expression is diminished in type-2 diabetes as well as in Alzheimer's disease (AD) patients, these data may provide a mechanistic link between insulin resistance, impaired synaptic transmission and cognitive decline in humans with metabolic disorders. 22661254 2012
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 GeneticVariation group BEFREE In contrast to focal islet-cell hyperplasia, always sporadic to our knowledge, diffuse hyperinsulinism is a heterogeneous disorder involving several genes, various mechanisms of pathogenic mutations and different transmissions: (i) channelopathy involving the genes encoding the sulphonylurea receptor (SUR1) or the inward-rectifying potassium channel (Kir6.2) in recessively inherited HI or more rarely dominantly inherited HI; (ii) metabolic disorders implicating the short-chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) enzyme inrecessively inherited HI, the glucokinase gene (GK), the glutamate dehydrogenase gene (GLUD1) when hyperammonemia is associated, dominant exercise-induced HI with still-unknown mechanism, and more recently the human insulin receptor gene in dominantly inherited hyperinsulinism. 15868462 2005
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 Biomarker group BEFREE Since the liver plays an essential role in the control of glucose homeostasis, we examined in this work whether the metabolic disorders of insulin receptor-deficient mice could be improved upon restoration of hepatic glucose metabolism by transgenic constitutive overexpression of glucokinase selectively in the liver. 12242462 2002
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 Biomarker group BEFREE Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. 11641236 2001
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases
0.090 GeneticVariation group BEFREE Total absence of the insulin receptor (IR), demonstrated in the homozygous mutant mice, also resulted in other metabolic disorders: plasma triglyceride level could increase 6-fold and hepatic glycogen content could be five times less as compared with normal littermates. 8612577 1996